STING1 and neoplasm: Moreover, STING, a crucial factor in the cGAS–Sting pathway, which contributes to the initiation of innate immunity and recognition of the tumor, was highly expressed in subtype 1 (P < 0.001) (Figure S11B), suggesting the impaired immunity initiation in subtype 2 and 3.